{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:38:54Z","timestamp":1790257134934,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"vor","delay-in-days":3236,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1177\/1087057112474468","type":"journal-article","created":{"date-parts":[[2013,1,30]],"date-time":"2013-01-30T23:17:19Z","timestamp":1359587839000},"page":"522-533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Using Human Pluripotent Stem Cell\u2013Derived Dopaminergic Neurons to Evaluate Candidate Parkinson\u2019s Disease Therapeutic Agents in MPP+ and Rotenone Models"],"prefix":"10.1016","volume":"18","author":[{"given":"Jun","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendra S.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianmin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1177\/1087057112474468_bib1","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s Disease: Mechanisms and Models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1177\/1087057112474468_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","article-title":"Neuropathology of Parkinson\u2019s Disease","volume":"55","author":"Forno","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1177\/1087057112474468_bib3","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson\u2019s Disease: First of Two Parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1177\/1087057112474468_bib4","first-page":"348","article-title":"Novel Neuroprotective Mechanism of Action of Rasagiline Is Associated with Its Propargyl Moiety: Interaction of Bcl-2 Family Members with PKC Pathway","volume":"1053","author":"Weinreb","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1177\/1087057112474468_bib5","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1096\/fj.05-3794fje","article-title":"Regulation of Bcl-2 Family Proteins, Neurotrophic Factors, and APP Processing in the Neurorescue Activity of Propargylamine","volume":"19","author":"Bar-Am","year":"2005","journal-title":"FASEB J."},{"key":"10.1177\/1087057112474468_bib6","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1038\/sj.npp.1301125","article-title":"An In Vitro Model of Human Dopaminergic Neurons Derived from Embryonic Stem Cells: MPP+ Toxicity and GDNF Neuroprotection","volume":"31","author":"Zeng","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1177\/1087057112474468_bib7","doi-asserted-by":"crossref","first-page":"e6233","DOI":"10.1371\/journal.pone.0006233","article-title":"Xeno-free Defined Conditions for Culture of Human Embryonic Stem Cells, Neural Stem Cells and Dopaminergic Neurons Derived from Them","volume":"4","author":"Swistowski","year":"2009","journal-title":"PLoS One"},{"key":"10.1177\/1087057112474468_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/scd.2009.0107","article-title":"Stage-Specific Role for shh in Dopaminergic Differentiation of Human Embryonic Stem Cells Induced by Stromal Cells","volume":"19","author":"Swistowska","year":"2010","journal-title":"Stem Cells Dev."},{"key":"10.1177\/1087057112474468_bib9","doi-asserted-by":"crossref","first-page":"32626","DOI":"10.1074\/jbc.M404596200","article-title":"The Herbicide Paraquat Induces Dopaminergic Nigral Apoptosis through Sustained Activation of the JNK Pathway","volume":"279","author":"Peng","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1177\/1087057112474468_bib10","doi-asserted-by":"crossref","first-page":"44285","DOI":"10.1074\/jbc.M207407200","article-title":"Inhibition of Caspases Protects Cerebellar Granule Cells of the Weaver Mouse from Apoptosis and Improves Behavioral Phenotype","volume":"277","author":"Peng","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1177\/1087057112474468_bib11","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/stem.499","article-title":"Efficient Generation of Functional Dopaminergic Neurons from Human Induced Pluripotent Stem Cells under Defined Conditions","volume":"28","author":"Swistowski","year":"2010","journal-title":"Stem Cells"},{"key":"10.1177\/1087057112474468_bib12","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of Active Nerve Cell Degeneration in the Substantia Nigra of Humans Years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1177\/1087057112474468_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.60.1.69","article-title":"Randomized, Double-Blind Trial of Glial Cell Line-Derived Neurotrophic Factor (GDNF) in PD","volume":"60","author":"Nutt","year":"2003","journal-title":"Neurology"},{"key":"10.1177\/1087057112474468_bib14","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic Systemic Pesticide Exposure Reproduces Features of Parkinson\u2019s Disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1177\/1087057112474468_bib15","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.8493557","article-title":"GDNF: A Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons","volume":"260","author":"Lin","year":"1993","journal-title":"Science"},{"key":"10.1177\/1087057112474468_bib16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1471-4159.1998.71020517.x","article-title":"Glial Cell Line-Derived Neurotrophic Growth Factor Inhibits Apoptotic Death of Postnatal Substantia Nigra Dopamine Neurons in Primary Culture","volume":"71","author":"Burke","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1177\/1087057112474468_bib17","doi-asserted-by":"crossref","first-page":"8818","DOI":"10.1073\/pnas.94.16.8818","article-title":"Intrastriatal Injection of an Adenoviral Vector Expressing Glial-Cell-Line-Derived Neurotrophic Factor Prevents Dopaminergic Neuron Degeneration and Behavioral Impairment in a Rat Model of Parkinson Disease","volume":"94","author":"Bilang-Bleuel","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1177\/1087057112474468_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/373335a0","article-title":"Protection and Repair of the Nigrostriatal Dopaminergic System by GDNF In Vivo","volume":"373","author":"Tomac","year":"1995","journal-title":"Nature"},{"key":"10.1177\/1087057112474468_bib19","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1126\/science.290.5492.767","article-title":"Neurodegeneration Prevented by Lentiviral Vector Delivery of GDNF in Primate Models of Parkinson\u2019s Disease","volume":"290","author":"Kordower","year":"2000","journal-title":"Science"},{"key":"10.1177\/1087057112474468_bib20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/mds.22402","article-title":"Long-term Outcome of Early versus Delayed Rasagiline Treatment in Early Parkinson\u2019s Disease","volume":"24","author":"Hauser","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1177\/1087057112474468_bib21","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.1016\/S0021-9258(19)57434-8","article-title":"Energy-Dependent Uptake of N-methyl-4-phenylpyridinium, the Neurotoxic Metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by Mitochondria","volume":"261","author":"Ramsay","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1177\/1087057112474468_bib22","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ana.410300304","article-title":"Mitochondrial Oxidative Phosphorylation Defects in Parkinson\u2019s Disease","volume":"30","author":"Shoffner","year":"1991","journal-title":"Ann. Neurol."},{"issue":"Pt 2","key":"10.1177\/1087057112474468_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/brain\/115.2.333","article-title":"Brain, Skeletal Muscle and Platelet Homogenate Mitochondrial Function in Parkinson\u2019s Disease","volume":"115","author":"Mann","year":"1992","journal-title":"Brain"}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1087057112474468","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1087057112474468","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555222075062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555222075062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1087057112474468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T11:38:25Z","timestamp":1762861105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472555222075062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S2472555222075062"],"URL":"https:\/\/doi.org\/10.1177\/1087057112474468","relation":{},"ISSN":["2472-5552"],"issn-type":[{"value":"2472-5552","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using Human Pluripotent Stem Cell\u2013Derived Dopaminergic Neurons to Evaluate Candidate Parkinson\u2019s Disease Therapeutic Agents in MPP+ and Rotenone Models","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1177\/1087057112474468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Society for Laboratory Automation and Screening. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}